Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Revenue
€ 42,100
Profit
Caution€ -1.7 million
▲ 24% vs 2024
Debts
High€ 6 million
▲ 84% vs 2024
ExoXpert from Liège, company number BE1003807666, closed financial year 2025 with a result of € -1.7 million after tax. For that financial year ExoXpert recorded revenue of € 42,100 and equity of € -3.9 million. Compared with financial year 2024, the result moved from € -2.2 million to € -1.7 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.
What happened at ExoXpert?
What happened at ExoXpert in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 1.7 million. Source: NBB ↗
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
- Stijn Van Rompay became a director. NBB
In short
From € 2.2 million loss in 2024 to € 1.7 million loss in 2025.
Paid € 1,779 in corporate taxes since 2024.
On average € 87,600 of value added per employee in 2025.
A new publication or filing at ExoXpert? We notify you, reason included.
Follow ExoXpertNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind ExoXpert is Stijn Van Rompay . Stijn Van Rompay is also behind J.D.P. Consult, SVR INVEST, SVR Management, DERMAX and Hyloris.
Directors
According to the 2025 annual accounts
since 2023
Establishments
Establishment units
Physical locations of this company
Boulevard de Patience et Beaujonc 3 box 2
4000 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 23 companies are registered at this address.
Hyloris Developments
€ 5.1 million revenue · 2025
ONCORADIOMICS
€ 2.4 million gross margin · 2025
DERMAX same network
€ 1.6 million revenue · 2025
Hyloris same network
€ 384,852 revenue · 2025
Hyloris Pharmaceuticals same network
€ 3.8 million revenue · 2025
+18 more
Details
- Company number
- 1003.807.666
- VAT number
- BE 1003.807.666
- Registered office
- Boulevard de Patience et Beaujonc 3 bus 2, 4000 Liège
- Names & denominations
- ExoXpert
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 December 2023
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Vervaardiging van overige farmaceutische producten
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Groothandel in farmaceutische en medische artikelen
Overige gespecialiseerde wetenschappelijke en technische activiteiten